Diet and Drug Treatment of Gout

  • W. Gröbner
Conference paper

Abstract

The treatment of gout has two goals, immediate control of acute attacks of gouty arthritis and long-term control of hyperuricaemia.

Keywords

Uric Acid Serum Uric Acid Serum Uric Acid Level Gouty Arthritis Orotic Acid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Band PR, Silverberg DS, Henderson JF, Ulan RA, Wensel RH, Banerjee TK, Little AS (1970) Xanthine nephropathy in a patient with lymphosarcoma treated with allopurinol. N Engl J Med 283:354PubMedCrossRefGoogle Scholar
  2. Beardmore TD, Cashman JS, Kelley WN (1972) Mechanism of allopurinol mediated increase in enzyme activity in man. J Clin Invest 51:1823PubMedCrossRefGoogle Scholar
  3. Berlinger WG, Park GD, Spector R (1985) The effect of dietary protein on the clearance of allopurinol and oxipurinol. N Engl J Med 313:771PubMedCrossRefGoogle Scholar
  4. Colling M, Wolfram G (1987) Zum Einfluß des Garens auf den Puringehalt von Lebensmitteln. Z Ernährungswiss 26:214PubMedCrossRefGoogle Scholar
  5. Elion GB (1966) Enzymatic and metabolic studies with allopurinol. Ann Rheum Dis 25:608PubMedGoogle Scholar
  6. Elion GB, Yü TF, Gutman AB, Hitchings GH (1968) Renal clearance of oxipurinol, the chief metabolite of allopurinol. Am J Med 45:69PubMedCrossRefGoogle Scholar
  7. Fox IJ, Wyngaarden JB, Kelley WN (1970) Depletion of erythrocyte phosphoribosylpyro-phosphate in man, a newly observed effect of allopurinol. N Engl J Med 283:1177PubMedCrossRefGoogle Scholar
  8. Fox RM, Royse-Smith D, O’Sullivan WJ (1970) Orotidinuria induced by allopurinol. Science 168:861PubMedCrossRefGoogle Scholar
  9. Gröbner W, Kelley WN (1975) Effect of allopurinol and its metabolic derivatives on the configuration of human orotate phosphoribosyltransferase and orotidine-5-phosphate decarboxylase. Biochem Pharmacol 24:379PubMedCrossRefGoogle Scholar
  10. Gröbner W, Zöllner N (1976) Uricosurica. In: Zöllner N, Gröbner W (eds) Gicht. Springer, Berlin Heidelberg New York, p 491, (Handbuch der Inneren Medizin, vol 7/3)Google Scholar
  11. Gröbner W, Zöllner N (1983) Der Einfluß von Nahrungspurinen und-pyrimidinen auf die Pyrimidinsynthese des Menschen. Klin Wochenschr 61:1191PubMedCrossRefGoogle Scholar
  12. Gutman AB, Yü TF (1952) Gout, a derangement of purine metabolism. Adv Intern Med 5:227PubMedGoogle Scholar
  13. Löffler W (1982) Urikosurika. In: Zöllner N (ed) Therapie und Prognose von Hyperurikämie und Gicht. Springer, Berlin Heidelberg New York, p 73 (Hyperurikämie und Gicht, vol 5)Google Scholar
  14. Löffler W, Gröbner W (1988) A study of dose-response relationships of allopurinol in the presence of low or high purine turnover. Klin Wochenschr 66:153PubMedCrossRefGoogle Scholar
  15. Löffler W, Gröbner W, Zöllner N (1983) Harnsäuresenkende Wirkung einer Kombination von Benzbromaron und Allopurinol-Untersuchungen unter standardisierten Ernährungsbedingungen. Arzneimittelforschung 33(11): 1687PubMedGoogle Scholar
  16. Reiter S, Löffler W, Gröbner W, Zöllner N (1984) Influence of dietary purines on the metabolism of allopurinol in man. World Rev Nutr Diet 43:187PubMedGoogle Scholar
  17. Rundles RW (1985) The development of allopurinol. Arch Intern Med 145:1492PubMedCrossRefGoogle Scholar
  18. Rundles RW, Wyngaarden JB, Hitchings GH, Elion GB, Silberman HR (1963) Effects of xanthine oxidase inhibitor on thiopurine metabolism, hyperuricemia and gout. Trans Assoc Am Physicians 76:126Google Scholar
  19. Seegmiller JE, Grayzel AJ (1960) Use of the newer uricosuric agents in the management of gout. JAMA 173:1076PubMedGoogle Scholar
  20. Simmonds HA, Rising TJ, Cadenhead A, Hatfield PJ, Jones A, Cameron JS (1973) Radioisotope studies of purine metabolism during administration of guanine and allopurinol in the pig. Biochem Pharmacol 22:2553CrossRefGoogle Scholar
  21. Wyngaarden JB, Kelley WN (1983) “Gout”. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS (eds) The metabolic basis of inherited disease, 5th edn. Mc Graw-Hill, New York, p 1043Google Scholar
  22. Yü TF, Gutman AB (1961) Efficacy of colchicine prophylaxis in gout. Ann Intern Med 55:179PubMedGoogle Scholar
  23. Zöllner N (1975) Diet and gout. Nutrition 1:267Google Scholar
  24. Zöllner N, Gröbner W (1970) Der unterschiedliche Einfluß von Allopurinol auf die endogene und exogene Uratquote. Eur J Clin Pharmacol 3:56CrossRefGoogle Scholar
  25. Zöllner N, Gröbner W (1971) Influence of oral ribonucleic acid on orotaciduria due to allopurinol administration. Z Gesamte Exp Med 156:317PubMedCrossRefGoogle Scholar
  26. Zöllner N, Gröbner W (1987) Purinstoffwechsel; Urikosurika, Urikostatika. Pharmakotherapie der Gicht. In: Forth W, Henschler D, Rummel W (eds) Allgemeine und spezielle Pharmakologie und Toxikologie. Wissenschaftsverlag, B. J., p 362Google Scholar
  27. Zöllner N, Griebsch A, Gröbner W (1972) Einfluß verschiedener Purine auf den Harnsäurestoffwechsel. Ernährungsumschau 3:79Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • W. Gröbner

There are no affiliations available

Personalised recommendations